Sponsor: 
Pfizer Australia
Administration route: 
Intramuscular injection
Vaccine group: 
Monovalent vaccines

Registered for use in children aged ≥8 weeks and in adults.

MenC — monovalent meningococcal serogroup C–tetanus toxoid conjugate vaccine

Each 0.5 mL monodose pre-filled syringe contains:

  • 10 µg Neisseria meningitidis serogroup C
  • 10–20 µg tetanus toxoid protein

Adsorbed onto 1.4 mg aluminium hydroxide.

For full details, refer to the product information and consumer medicine information sheets for NeisVac-C vaccine available on the TGA website.

Page history

Last updated: 
4 June 2018
Last reviewed: 
4 June 2018